Skip to main content

RETRACTION article

Front. Pharmacol., 27 August 2024
Sec. Inflammation Pharmacology
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1483859
This article is part of the Research Topic Oxidative Stress and Neural Inflammation in Peripheral Nervous System View all 5 articles

Retraction: Effects of dexmedetomidine on postoperative delirium and expression of IL-1β, IL-6, and TNF-α in elderly patients after hip fracture operation

This article is a retraction of:

  1. RETRACTED: Effects of Dexmedetomidine on Postoperative Delirium and Expression of IL-1β, IL-6, and TNF-α in Elderly Patients After Hip Fracture Operation

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A retraction of the Clinical Trial Article
Effects of dexmedetomidine on postoperative delirium and expression of IL-1β, IL-6, and TNF-α in elderly patients after hip fracture operation

by Zhang W, Wang T, Wang G, Yang M, Zhou Y and Yuan Y (2020). Front. Pharmacol. 11:678. doi: 10.3389/fphar.2020.00678

The journal retracts the 12 May 2020 article cited above.

Following publication, concerns were raised regarding the clinical trial registration for this study. An investigation was conducted in accordance with Frontiers’ policies, and it was confirmed that, contrary to the statements in the article, the study was not an accurate reflection of the study registered with the clinical trial registry. Lack of appropriate clinical trial registration is a breach of Frontiers’ guidelines and those of the Committee on Publication Ethics. As such, this article is being retracted. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Frontiers would like to thank Prof. John Loadsman for contacting the journal regarding the published article.

Citation: Frontiers Editorial Office (2024) Retraction: Effects of dexmedetomidine on postoperative delirium and expression of IL-1β, IL-6, and TNF-α in elderly patients after hip fracture operation. Front. Pharmacol. 15:1483859. doi: 10.3389/fphar.2024.1483859

Received: 20 August 2024; Accepted: 20 August 2024;
Published: 27 August 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.